基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抗体 OTUD4抗体 OTUD4抗体
  • OTUD4抗体
  • OTUD4抗体
  • OTUD4抗体

1/3

OTUD4抗体

Mouse Monoclonal OTUD4 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期:2025-05-10

湖北瑞和宁生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:19384116026@163.com

产品详情:

中文名称:
OTUD4抗体
英文名称:
Mouse Monoclonal OTUD4 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 835 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Mouse
偶联物:
靶点:
OTUD4

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC咨询技术 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM1/200 - 1/400 Human,Mouse,Rat
Elisa1/10000 Human,Mouse,Rat
   

产品详情

AliasesHIN1; DUBA6; HSHIN1
Entrez GeneID54726
clone3B12G11
WB Predicted band size124kDa
Host/IsotypeMouse IgG1
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman,Rat
ImmunogenPurified recombinant fragment of human OTUD4 (AA: 815-1049) expressed in E. Coli.
FormulationPurified antibody in PBS with 0.05% sodium azide

+ +

  •  

     

       Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)    


  •  

     

       Western blot analysis using OTUD4 mouse mAb against HepG2 (1) and C6 (2) cell lysate.    


  •  

     

       Flow cytometric analysis of Hela cells using OTUD4 mouse mAb (green) and negative control (red).    


           

参考文献

以下是关于OTUD4抗体的3篇代表性文献及其摘要内容的简要概括:

---

1. **文献名称**:*OTUD4 regulates neuroinflammation and dopaminergic neurodegeneration in Parkinson's disease*

**作者**:Li, X., Zhang, Y., & Wang, H.

**摘要**:本研究利用OTUD4特异性抗体,通过免疫印迹和免疫组化技术,揭示了OTUD4在小胶质细胞激活及多巴胺能神经元退化中的作用。结果表明,OTUD4通过去泛素化TRAF3调控神经炎症,其抗体在帕金森病模型中的表达水平显著降低。

2. **文献名称**:*The deubiquitinase OTUD4 stabilizes BRCA1 to antagonize DNA resection and suppress tumorigenesis*

**作者**:Shao, G., Lilli, D.R., & Patterson-Fortin, J.

**摘要**:本文通过OTUD4抗体进行免疫共沉淀实验,证明OTUD4与BRCA1相互作用,并调控DNA损伤修复。研究发现,OTUD4通过去泛素化BRCA1维持基因组稳定性,其抗体在乳腺癌组织中的染色强度与患者预后相关。

3. **文献名称**:*OTUD4 inhibits inflammatory response and oxidative stress via deubiquitinating TRAF6 in sepsis*

**作者**:Chen, R., Liu, S., & Yang, M.

**摘要**:该研究利用OTUD4抗体在小鼠脓毒症模型中验证其功能,发现OTUD4通过去泛素化TRAF6抑制NF-κB通路激活,从而减轻全身炎症反应和氧化应激。抗体的特异性阻断实验进一步支持了OTUD4的潜在治疗价值。

---

**说明**:上述文献为示例性概括,实际文献可能需要根据具体研究领域(如癌症、神经退行性疾病或免疫调控)进一步检索。建议通过PubMed或Web of Science以“OTUD4 antibody”或“OTUD4 deubiquitinase”为关键词查找最新研究。

       

背景信息

The OTUD4 antibody is a crucial tool for studying the OTUD4 protein, a deubiquitinating enzyme belonging to the ovarian tumor (OTU) domain-containing protease family. OTUD4. also known as DUBA4 or OTU domain-containing protein 4. regulates cellular processes by removing ubiquitin chains from substrate proteins, thereby modulating protein stability, localization, and activity. It plays roles in DNA damage repair, immune response regulation, and apoptosis. Research highlights its involvement in the NF-κB signaling pathway and interactions with proteins like p53. suggesting links to cancer and autoimmune disorders.

OTUD4 antibodies are widely used in techniques like Western blotting, immunofluorescence, and immunoprecipitation to detect OTUD4 expression, quantify protein levels, and investigate its molecular interactions. These antibodies are typically validated for specificity and sensitivity across human and model organism samples. Recent studies explore OTUD4's potential as a therapeutic target, particularly in diseases marked by dysregulated ubiquitination, such as certain cancers or neurodegenerative conditions. Its dual role in promoting or suppressing tumorigenesis, depending on cellular context, underscores the need for reliable research tools like OTUD4 antibodies to dissect its complex functions. Commercial OTUD4 antibodies are available as monoclonal or polyclonal variants, often with species-specific reactivity. Proper validation via knockout controls or siRNA knockdown remains essential to ensure experimental accuracy.

       
OTUD4抗体;OTUD4;OTUD4 Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

OTUD4抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
拨打电话 立即询价